BHV-3241

· Biohaven Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BHV-3241, covering 2023-09-29 to 2023-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of BHV-3241 in Participants With Multiple System Atrophy [Phase 3]